Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical AS101 for External Genital Warts
NCT01555112Phase 2Completed
- Sponsor
- BioMAS Ltd
- Start
- Mar 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of AS-101 in condyloma acuminata, sponsored by BioMAS Ltd. Primary endpoint: Number of patients with Adverse Events and their severity at 16 weeks. Started Mar 2012; status: completed.
02
Drugs
AS-101
03
Conditions
condyloma acuminata
Beyond the preview
Go deeper on NCT01555112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01555112.